GlassScriptPhysician profile
Bruce V Lattyak
NPI 1629245238
$8,038.96
in general payments reported to CMS, 2019-2025
7 companies · $1,981 in 2025
The $1,981 reported for 2025 was more than what 84% of Plastic Surgery providers received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,822 · 2020: $57.89 · 2021: $552 · 2022: $37.78 · 2023: $200 · 2024: $2,388 · 2025: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,022 · Food and Beverage: $1,546.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,022.37 |
| Food and Beverage | $1,546.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $3,281.85 | 2019-2021 | |
| Abbvie INC. | $2,699.72 | 2023-2025 | |
| Medtronic, INC. | $1,820.16 | 2025 | Venaseal |
| Merz North America, INC. | $90.33 | 2019 | |
| Galderma Laboratories, L.P. | $83.15 | 2021-2023 | |
| Smith+Nephew, INC. | $47.08 | 2021 | |
| Biotissue Holdings INC. | $16.67 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Lattyak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.